Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2024

  • Report ID:MRHC - 104252
  • Pages: 185
  • Apr 2019
  • Formats*: PDF
  • Category: Healthcare

1. Introduction 
    1.1. Market Ecosystem  
    1.2. Currency & Limitation   
          1.2.1. Currency
          1.2.2. Limitations
    1.3. Key Stakeholders

2. Research Methodology 
    2.1. Research Pocesss
          2.1.1. Secondary Research 
          2.1.2. Primary Research 
          2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights 
    4.1. Introduction
    4.2. Market Dynamics
          4.2.1. Drivers 
                    4.2.1.1. Growing Adoption of Synthesized Oligonucleotides in Diagnostics and Clinical Applications 
                    4.2.1.2. Rising R&D Expenditure and Government Investment in Pharmaceutical and Biotechnology Companies 
                    4.2.1.3. Plummeting Cost of Sequencing 
                    4.2.1.4. Increasing Public-Private Spending on Genomics 
                    4.2.1.5. Rising Venture Capital Investments/Funding 
          4.2.2. Restraints 
                    4.2.2.1. Lack of Regulations for Therapeutic Oligos 
                    4.2.2.2. Price Erosion of Synthesized Oligonucleotides 
          4.2.3. Opportunities 
                    4.2.3.1. Emerging Asian Markets 
                    4.2.3.2. Therapeutic Oligos 
          4.2.4. Challenges  
                    4.2.4.1. Large-Scale Synthesis of Oligonucleotides 
                    4.2.4.2. Delivery of Oligonucleotide Drugs to Specific Targets

5. Oligonucleotide Synthesis Market, by Product & Services
    5.1. Introduction 
    5.2. Oligonucleotide Synthesis Products
          5.2.1. Oligonucleotide Synthesis Equipment (Synthesizers)
          5.2.2. Oligonucleotide Synthesis Reagents & Consumables 
    5.3. Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)
          5.3.1. Primers
          5.3.2. Probes
          5.3.3. Linkers & Adaptors
    5.4. Custom Oligonucleotide Synthesis Services (Custom Oligonucleotides)
          5.4.1. Large-Scale Oligonucleotide Synthesis
          5.4.2. Intermediate-Scale Oligonucleotide Synthesis
          5.4.3. Small-Scale Oligonucleotide Synthesis

6. Oligonucleotide Synthesis Market, by Application 
    6.1. Introduction 
    6.2. Research  
          6.2.1. PCR 
          6.2.2. qPCR/RTqPCR 
          6.2.3. Sequencing 
          6.2.4. Gene Synthesis 
          6.2.5. Other Research Applications 
    6.3. Diagnostics 
    6.4. Therapeutics  
          6.4.1. RNAi Oligonucleotide-based Therapies
          6.4.2. DNA/Antisense Oligonucleotide-based Therapies 
          6.4.3. Immunotherapy (CpG Oligonucleotide-based Therapies) 
          6.4.4. Nucleic Acid Aptamers

7. Oligonucleotide Synthesis Market, by End User 
    7.1. Introduction 
    7.2. Pharmaceutical and Biotechnology Companies  
    7.3. Academic Research Institutes  
    7.4. Diagnostic Laboratories  
    7.5. Others  

8. Oligonucleotide Synthesis Market, by Geography  
    8.1. North America 
          8.1.1. U.S.
          8.1.2. Canada
    8.2. Europe 
          8.2.1. Germany 
          8.2.2. France
          8.2.3. U.K.
          8.2.4. Italy
          8.2.5. Spain
          8.2.6. Rest of Europe
    8.3. Asia-Pacific  
          8.3.1. Japan
          8.3.2. China
          8.3.3. India
          8.3.4. Rest of Asia-Pacific
    8.4. Rest of the World 
          8.4.1. Latin America
          8.4.2. Middle East & Africa

9. Competitive Landscape
    9.1. Competitive Benchmarking
    9.2. Market Share Analysis  

10. Company Profiles 
      10.1. Danaher Corporation 
              10.1.1. Business Overview
              10.1.2. Financial Overview   
              10.1.3. Product Portfolio    
              10.1.4. Strategic Developments   
      10.2. Merck KGaA (Sigma-Aldrich Co. LLC) 
              10.2.1. Business Overview
              10.2.2. Financial Overview    
              10.2.3. Product Portfolio     
              10.2.4. Strategic Developments 
      10.3. Eurofins Genomics LLC (Part of Eurofins Scientific SE)
              10.3.1. Business Overview    
              10.3.2. Financial Overview    
              10.3.3. Product Portfolio 
              10.3.4. Strategic Developments 
      10.4. Thermo Fisher Scientific, Inc. 
              10.4.1. Business Overview     
              10.4.2. Financial Overview    
              10.4.3. Products Portfolio
              10.4.4. Strategic Developments
      10.5. Agilent Technologies, Inc. 
              10.5.1. Business Overview    
              10.5.2. Financial Overview    
              10.5.3. Product Portfolio
              10.5.4. Strategic Developments
      10.6. GE Healthcare 
              10.6.1. Business Overview     
              10.6.2. Financial Overview    
              10.6.3. Product Portfolio
              10.6.4. Strategic Developments
      10.7. GeneDesign Inc. (Part of Ajinomoto Co., Inc.)  
              10.7.1. Business Overview     
              10.7.2. Financial Overview     
              10.7.3. Product Portfolio
              10.7.4. Strategic Developments
      10.8. Kaneka Eurogentec S.A. (Part of Kaneka Corporation)
              10.8.1. Business Overview
              10.8.2. Financial Overview 
              10.8.3. Products Portfolio
              10.8.4. Strategic Developments
      10.9. LGC Biosearch Technologies 
              10.9.1. Business Overview     
              10.9.2. Financial Overview     
              10.9.3. Product Portfolio
              10.9.4. Strategic Developments
      10.10. Bio-synthesis Inc. 
              10.10.1. Business Overview 
              10.10.2. Financial Overview          
              10.10.3. Product Portfolio
              10.10.4. Strategic Developments
      10.11. TriLink Biotechnologies LLC (Part of Maravai Lifesciences)  
              10.11.1. Business Overview     
              10.11.2. Financial Overview     
              10.11.3. Product Portfolio
              10.11.4. Strategic Developments
      10.12. ATDBio Ltd. 
              10.12.1. Business Overview
              10.12.2. Financial Overview
              10.12.3. Product Portfolio
              10.12.4. Strategic Developments

11. Appendix
      11.1. Questionnaire
      11.2. Available Customization  

List of Tables

Table 1 Oligonucleotide Synthesis Market Drivers: Impact Analysis (2018–2024)
Table 2 Global Oligonucleotide Synthesis Market Restraints: Impact Analysis (2018-2024)
Table 3 Global Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 4 Global Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 5 Global Oligonucleotide Synthesis Products Market Size, by Country, 2017-2024 ($Million)
Table 6 Global Oligonucleotide Synthesizers Market Size, by Country, 2017-2024 ($Million)
Table 7 Global Oligonucleotide Synthesis Reagents & Consumables Market Size, by Country, 2017-2024 ($Million)
Table 8 Global Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 9 Global Synthesized Oligonucleotides Market Size, by Country, 2017-2024 ($Million)
Table 10 Global Synthesized Oligonucleotide Primers Market Size, by Country, 2017-2024 ($Million)
Table 11 Global Synthesized Oligonucleotide Probes Market Size, by Country, 2017-2024 ($Million)
Table 12 Global Synthesized Oligonucleotide Linkers and Adapters Market Size, by Country, 2017-2024 ($Million)
Table 13 Global Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 14 Global Custom Oligonucleotide Synthesis Services Market Size, by Country, 2017-2024 ($Million)
Table 15 Global Large-Scale Oligonucleotide Synthesis Services Market Size, by Country, 2017-2024 ($Million)
Table 16 Global Intermediate-Scale Oligonucleotide Synthesis Services Market Size, by Country, 2017-2024 ($Million)
Table 17 Global Small-Scale Synthesis Oligonucleotide Synthesis Services Market Size, by Country, 2017-2024 ($Million)
Table 18 Global Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 19 Global Oligonucleotide Synthesis Market Size for Research, by Country, 2017-2024 ($Million)
Table 20 Global Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 21 Global Oligonucleotide Synthesis Market Size for PCR, by Country, 2017-2024 ($Million)
Table 22 Global Oligonucleotide Synthesis Market Size for qPCR/RTqPCR, by Country, 2017-2024 ($Million)
Table 23 Global Oligonucleotide Synthesis Market Size for Sequencing, by Country, 2017-2024 ($Million)
Table 24 Global Oligonucleotide Synthesis Market Size for Gene Synthesis, by Country, 2017-2024 ($Million)
Table 25 Global Oligonucleotide Synthesis Market Size for Other Research Applications, by Country, 2017-2024 ($Million)
Table 26 Global Oligonucleotide Synthesis Market Size for Diagnostics, by Country, 2017-2024 ($Million)
Table 27 Global Oligonucleotide Synthesis Market Size for Therapeutics, by Country, 2017-2024 ($Million)
Table 28 Global Oligonucleotide Synthesis Market Size for Therapeutic, by Type, 2017-2024 ($Million)
Table 29 Global Oligonucleotide Synthesis Market Size for RNAi Therapies, by Country, 2017-2024 ($Million)
Table 30 Global Oligonucleotide Synthesis Market Size for Antisense Oligonucleotides Therapies,
Table 31 Global Oligonucleotide Synthesis Market Size for  Immunotherapy, by Country, 2017-2024 ($Million)
Table 32 Global Oligonucleotide Synthesis Market Size for Nucleic Acid Aptamers, by Country, 2017-2024 ($Thousand)
Table 33 Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 34 Global Oligonucleotide Synthesis Market Size for Pharmaceutical and Biotechnology Companies, by Country, 2017-2024 ($Million)
Table 35 Global Oligonucleotides Synthesis Market Size for Academic Research Institutes, by Country, 2017-2024 ($Million)
Table 36 Global Oligonucleotide Synthesis Market Size for Diagnostic Laboratories, by Country, 2017-2024 ($Million)
Table 37 Global Oligonucleotide Synthesis Market Size for Other End Users, by Country, 2017-2024 ($Million)
Table 38 Global Oligonucleotide Synthesis Market Size, by Geography, 2017-2024 ($Million)
Table 39 North America: Oligonucleotide Synthesis Market Size, by Country, 2017-2024 ($Million)
Table 40 North America: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 41 North America: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 42 North America: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 43 North America: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 44 North America: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 45 North America: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 46 North America: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 47 North America: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 48 U.S.: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 49 U.S.: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 50 U.S.: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 51 U.S.: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 52 U.S.: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 53 U.S.: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 54 U.S.: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 55 U.S.: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 56 Canada: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 57 Canada: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 58 Canada: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 59 Canada: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 60 Canada: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 61 Canada: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 62 Canada: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 63 Canada: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 64 Europe: Oligonucleotide Synthesis Market Size, by Country, 2017-2024 ($Million)
Table 65 Europe: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 66 Europe: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 67 Europe: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 68 Europe: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 69 Europe: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 70 Europe: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 71 Europe: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 72 Europe: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 73 Germany: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 74 Germany: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 75 Germany: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 76 Germany: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 77 Germany: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 78 Germany: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 79 Germany: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 80 Germany: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 81 France: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 82 France: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 83 France: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 84 France: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 85 France: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 86 France: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 87 France: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 88 France: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 89 U.K.: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 90 U.K.: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 91 U.K.: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 92 U.K.: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 93 U.K.: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 94 U.K.: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 95 U.K.: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 96 U.K.: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 97 Italy: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 98 Italy: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 99 Italy: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 100 Italy: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 101 Italy: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 102 Italy: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 103 Italy: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 104 Italy: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 105 Spain: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 106 Spain: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 107 Spain: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 108 Spain: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 109 Spain: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 110 Spain: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 111 Spain: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 112 Spain: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 113 RoE: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 114 RoE: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 115 RoE: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 116 RoE: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 117 RoE: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 118 RoE: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 119 RoE: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 120 RoE: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 121 APAC: Oligonucleotide Synthesis Market Size, by Country, 2017-2024 ($Million)
Table 122 APAC: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 123 APAC: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 124 APAC: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 125 APAC: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 126 APAC: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 127 APAC: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 128 APAC: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 129 APAC: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 130 China: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 131 China: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 132 China: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 133 China: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 134 China: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 135 China: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 136 China: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 137 China: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 138 Japan: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 139 Japan: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 140 Japan: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 141 Japan: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 142 Japan: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 143 Japan: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 144 Japan: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 145 Japan: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 146 India: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 147 India: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 148 India: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 149 India: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 150 India: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 151 India: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 152 India: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 153 India: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 154 RoAPAC: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 155 RoAPAC: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 156 RoAPAC: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 157 RoAPAC: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 158 RoAPAC: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 159 APAC: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 160 RoAPAC: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 161 RoAPAC: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 162 RoW: Oligonucleotide Synthesis Market Size, by Region, 2017-2024 ($Million)
Table 163 RoW: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 164 RoW: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 165 RoW: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 166 RoW: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 167 RoW: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 168 RoW: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 169 RoW: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 170 RoW: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 171 Latin America: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 172 Latin America: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 173 Latin America: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 174 Latin America: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 175 Latin America: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 176 Latin America: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 177 Latin America: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 178 Latin America: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 179 Middle East & Africa: Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Table 180 Middle East & Africa: Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Table 181 Middle East & Africa: Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Table 182 Middle East & Africa: Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Table 183 Middle East & Africa: Oligonucleotide Synthesis Market Size, by Application, 2017-2024 ($Million)
Table 184 Middle East & Africa: Oligonucleotide Synthesis Market Size for Research, by Type, 2017-2024 ($Million)
Table 185 Middle East & Africa: Oligonucleotide Synthesis Market Size for Therapeutics, by Type, 2017-2024 ($Million)
Table 186 Middle East & Africa: Oligonucleotide Synthesis Market Size, by End User, 2017-2024 ($Million)
Table 187 Number of Developments by the Major Players during 2015-2018
Table 188 Key Products: Synthesized Oligonucleotides

List of Figures

Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Key Opportunities
Figure 5 Oligonucleotide Synthesis Market, by Product & Services
Figure 6 Oligonucleotide Synthesis Market, by Application
Figure 7 Oligonucleotide Synthesis Market, by End User
Figure 8 Oligonucleotide Synthesis Market, by Region
Figure 9 Market Dynamics
Figure 10 Share of Medical and Health R&D Expenditure of U.S., by Type of Organization: 2015
Figure 11 Global Oligonucleotide Synthesis Market Size, by Product & Services, 2019-2024 ($Million)
Figure 12 Global Oligonucleotide Synthesis Market Size, by Product & Services, 2017-2024 ($Million)
Figure 13 Global Oligonucleotide Synthesis Products Market Size, by Type, 2017-2024 ($Million)
Figure 14 Global Synthesized Oligonucleotides Market Size, by Type, 2017-2024 ($Million)
Figure 15 Global Custom Oligonucleotide Synthesis Services Market Size, by Type, 2017-2024 ($Million)
Figure 16 Global Oligonucleotide Synthesis Market Size, by Application, 2019-2024 ($Million)
Figure 17 Global Oligonucleotide Synthesis Market Size, by End User, 2019-2024 ($Million)
Figure 18 Pharmaceutical R&D Spending, 2011-2017
Figure 19 Global Oligonucleotide Synthesis Market Size, by Geography, 2019-2024 ($Million)
Figure 20 North America: Oligonucleotide Synthesis Market Size, by Country, 2019-2024 ($Million)
Figure 21 Number of People with Chronic Diseases in America: 2005-2030 (Million)
Figure 22 Number of People Aged 60 Years & Above in Europe, in 2017 Vs 2050 (In Million)
Figure 23 Europe: Oligonucleotide Synthesis Market Size, by Country, 2019-2024 ($Million)
Figure 24 Number of Biotech Companies With Business Segments, 2017
Figure 25 Spain: Proportion of Overweight Population (In %), 2000-2020
Figure 26 Spain: Life Expectancy Compared To European Union, 2000-2015
Figure 27 Proportion of Elderly Population in Poland, 2000-2030 (%)
Figure 28 APAC: Oligonucleotide Synthesis Market Size, by Country, 2019-2024 ($Million)
Figure 29 Share of Non-Communicable Diseases in Total Death in China, 2005-2020 (%)
Figure 30 Japan: % of Population Aged 65 Years & Above, 1950-2050 (%)
Figure 31 RoW: Oligonucleotide Synthesis Market Size, by Country, 2019-2024 ($Million)
Figure 32 Growth Strategies Adopted by the Key Players between 2015 and 2018
Figure 33 Oligonucleotide Synthesis Market: Competitive Benchmarking
Figure 34 Danaher Corporation: Financial Overview-2015-2017
Figure 35 Merck KGaA: Financial Overview-2015-2017
Figure 36 Eurofins Scientific: Financial Overview-2016-2018 
Figure 37 Thermo Fisher Scientific Inc.: Financial Overview-2015-2017 
Figure 38 Agilent Technologies, Inc.: Financial Overview-2015-2017
Figure 39 GE Healthcare: Financial Overview-2015-2017
Figure 40 Ajinomoto Co., Inc.: Financial Overview-2016-2018
Figure 41 Kaneka Corporation: Financial Overview-2016-2018

The global oligonucleotide synthesis market is expected to grow at a CAGR 10.5% from 2019 to 2024 to reach $2.9 billion by 2024.

The global oligonucleotide synthesis market is highly competitive and provides robust growth opportunities for biotechnology companies. The growth of this market is mainly attributed to the growing adoption of synthesized oligonucleotides in diagnostic and clinical applications, rising R&D expenditure and government investment in pharmaceutical and biotechnology companies, plummeting cost of sequencing, increasing public & private spending on genomics, and rising venture capital investments/funding. In recent years, this market has witnessed significant rise in acquisition of various small-scale oligonucleotide synthesis companies by major key players to broaden their product & service offerings and expand their presence in oligonucleotide synthesis market.

Plummeting cost of sequencing to fuel the growth of global oligonucleotide synthesis market

The recent advances in the field of genomics research over the past few years have led to substantial reduction in the cost of genome sequencing. The NGS technology has reduced the cost and increased the speed of DNA sequencing significantly. According to statistics from the National Human Genome Research Institute (NHGRI), the cost of sequencing a human genome has decreased substantially from ~$5 million in 2008 to ~$1000 in 2017. In genomics research field, sequencing is being applied not only to assemble genomes and to investigate the genetic basis of human diseases, but also to understand the diverse nature of reproductive medicine, oncology, and infectious diseases. Thus, the rapidly plummeting cost of sequencing would boost the research activities, thereby fuelling the demand of oligonucleotide synthesis during the forecast period.

For In-Depth Detail Get Sample Copy:https://www.meticulousresearch.com/request-sample-report/cp_id=4953

Key Findings in the global oligonucleotide synthesis market study:

Synthesized oligonucleotides dominates the oligonucleotide synthesis market, by product

Synthesized oligonucleotides accounted for the largest share over reagents/consumables and equipment of the global market in 2018, owing to the growing use of synthesized oligonucleotides in various biological research experiments to study critical diseases.

Research segment dominates the global oligonucleotide synthesis market, by application

In 2018, research segment commanded the largest share as compared to diagnostic and therapeutic applications. However, use of oligonucleotides for diagnostic applications is likely to grow at the highest CAGR during the forecast period. This is mainly due to developing applications of molecular diagnostics (MDx) and genetic testing.

Diagnostic laboratories to register the fastest CAGR

On the basis of end user, oligonucleotide synthesis market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. Academic research institutes commanded the largest share of the global oligonucleotide synthesis market in 2018. However, diagnostic laboratories are expected to register the highest CAGR during the forecast period owing to rising application of oligonucleotide in diagnostic applications.

North America dominates the global oligonucleotide synthesis market

In 2018, North America dominated the global oligonucleotide synthesis market, followed by Europe. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. Factors supporting growth for this region include the growing availability of synthesized oligonucleotides, strong presence of pharma & biotech companies, growing outsourcing to CROs, and increase in R&D funding and activities in the APAC region.

Key Players

The key players in the global oligonucleotide synthesis market are Integrated DNA Technologies, Inc. (U.S.) (Part of Danaher Corporation), Merck KGaA (Germany), Eurofins Scientific(Luxembourg), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), GE Healthcare (U.S.), GeneDesign, Inc. (Japan) (Part of Ajinomoto Co., Inc.), Kaneka Eurogentec (Belgium) (Part of Kaneka Corporation), LGC Biosearch Technologies (U.S.), Bio-synthesis Inc. (U.S.), TriLink BioTechnologies, LLC (U.S.) (Part of Maravai LifeSciences), and ATDBio Ltd. (U.K.) among others.

Future Outlook

In recent years, interest in oligonucleotide therapeutics has resurged with development of new approaches, clinical applications, advances in delivery, and a deeper biological understanding of these compounds. More recently, the strategy for delivering oligonucleotide therapeutics has changed from non-specific uptake, to targeted delivery. Although there remain some challenges, the development of oligonucleotide therapeutics is extremely promising.

Scope of the Report:

Oligonucleotide Synthesis Market By Product & Services

  • Oligonucleotide Synthesis Products
    • Oligonucleotide Synthesis Equipment (Synthesizers)
    • Oligonucleotide Synthesis Reagents & Consumables
  • Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)
    • Primers
    • Probes
    • Linkers & Adaptors
  • Custom Oligonucleotide Synthesis Services (Custom Oligonucleotides)
    • Large-Scale Oligonucleotide Synthesis
    • Intermediate-Scale Oligonucleotide Synthesis
    • Small-Scale Oligonucleotide Synthesis

Oligonucleotide Synthesis Market By Application

  • Research
    • PCR
    • QPCR/RTQPCR
    • Sequencing
    • Gene Synthesis
    • Other Research Applications
  • Diagnostics
  • Therapeutics
    • RNAi Oligonucleotide-based Therapies
    • DNA/Antisense oligonucleotide-based Therapies
    • Immunotherapy (CpG Oligonucleotide-based Therapies)
    • Nucleic Acid Aptamers

Oligonucleotide Synthesis Market By End User

  • Pharmaceutical And Biotechnology Companies
  • Academic Research Institutes
  • Diagnostic Laboratories
  • Others

Oligonucleotide Synthesis Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Rest of World
    • Latin America
    • Middle East & Africa

Key questions answered in the report:

Growing adoption of synthesized oligonucleotides are expected to propel the overall oligonucleotide synthesis market

  • How does the penetration of synthesized oligonucleotides in developed regions differ from developing countries like China, Japan, and India?
  • How is the competition between the major global and prominent local players in this market?
  • Which are the high growth market segments in terms of product, application, end users, and geography?

Academic Research Institutes accounted for the largest share of the oligonucleotide synthesis market

  • What factors are contributing to the frequent usage of oligonucleotides in academic and research institutes?
  • How does the penetration of oligonucleotides in academic and research institutes differ from other end users?

Oligonucleotide synthesis market favors both global and local manufacturers that compete in multiple segments

  • Who are the top competitors in this market and what strategies do they employ to gain shares?
  • Which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies look to enter in this market?
  • What are the major drivers, restraints, opportunities, and challenges in the oligonucleotide synthesis market?
  • What are the geographical trends and high growth regions/countries?

Recent partnerships, acquisitions, and expansions have taken place in the global oligonucleotide synthesis market

  • Which companies have recently merged/acquired and how will these unions affect the competitive landscape of the oligonucleotide synthesis market?
  • Which companies have created partnerships and how will these partnerships promote a competitive advantage?
  • Who are the major players in the global oligonucleotide synthesis market and what share of the market do they hold?
  • What are the local emerging players in the global oligonucleotide synthesis market and how do they compete with the global players?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare Medical Technologies
Download Free Sample